Premium
Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne–Stokes respiration
Author(s) -
Oldenburg Olaf,
Schmidt Anke,
Lamp Barbara,
Bitter Thomas,
Muntean Bogdan G.,
Langer Christoph,
Horstkotte Dieter
Publication year - 2008
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2008.04.007
Subject(s) - medicine , cheyne–stokes respiration , heart failure , ejection fraction , cardiology , anaerobic exercise , physical therapy
Background and aims Sleep disordered breathing (SDB), especially Cheyne–Stokes respiration (CSR) is common in patients with chronic heart failure (CHF). Adaptive servoventilation (ASV) was recently introduced to treat CSR in CHF. The aim of this study was to investigate the effects of ASV on CSR and CHF parameters. Methods In 29 male patients (63.9±9 years, NYHA≥II, left ventricular ejection fraction [LV‐EF]≤40%), cardiorespiratory polygraphy, cardiopulmonary exercise (CPX) testing, and echocardiography were performed and concentrations of NT‐proBNP determined before and after 5.8±3.5 months (median 5.7 months) of ASV (AutoSet CS™2, ResMed) treatment. All patients also received guideline‐driven CHF therapy. Results Apnoea–hypopnoea‐index was reduced from 37.4±9.4/h to 3.9±4.1/h ( p <0.001). Workload during CPX testing increased from 81±26 to 100±31 W ( p =0.005), oxygen uptake (VO 2 ) at the anaerobic threshold from 12.6±3 to 15.3±4 ml/kg/min ( p =0.01) and predicted peak VO 2 from 58±12% to 69±17% ( p =0.007). LV‐EF increased from 28.2±7% to 35.2±11% ( p =0.001), and NT‐proBNP levels decreased significantly (2285±2192 pg/ml to 1061±1293 pg/ml, p =0.01). Conclusions In selected patients with CHF and CSR, addition of ASV to standard heart failure therapy is able to improve SDB, CPX test results, LV‐EF and NT‐proBNP concentrations.